0001333277-18-000039.txt : 20180831 0001333277-18-000039.hdr.sgml : 20180831 20180831192400 ACCESSION NUMBER: 0001333277-18-000039 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180829 FILED AS OF DATE: 20180831 DATE AS OF CHANGE: 20180831 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Menold Daniel CENTRAL INDEX KEY: 0001705745 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36500 FILM NUMBER: 181050950 MAIL ADDRESS: STREET 1: C/O CYMABAY THERAPEUTICS, INC. STREET 2: 7999 GATEWAY BLVD., SUITE 130 CITY: NEWARK STATE: CA ZIP: 94560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc. CENTRAL INDEX KEY: 0001042074 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943103561 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7999 GATEWAY BLVD STREET 2: SUITE 130 CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-293-8800 MAIL ADDRESS: STREET 1: 7999 GATEWAY BLVD STREET 2: SUITE 130 CITY: NEWARK STATE: CA ZIP: 94560 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX, INC. DATE OF NAME CHANGE: 20090721 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX INC DATE OF NAME CHANGE: 19970710 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2018-08-29 0001042074 CymaBay Therapeutics, Inc. CBAY 0001705745 Menold Daniel C/O CYMABAY THERAPEUTICS, INC. 7999 GATEWAY BOULEVARD NEWARK CA 94560 0 1 0 0 Vice President, Finance Common Stock 2018-08-29 4 M 0 5000 5.00 A 5000 D Common Stock 2018-08-29 4 S 0 5000 13.00 D 0 D Employee Stock Option (right to buy) 5.00 2018-08-29 4 M 0 5000 0 D 2024-01-21 Common Stock 5000 14459 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The option vested as to 1/4 of the shares on January 22, 2015 and 1/36 per month thereafter. /s/ Daniel Menold 2018-08-31